DCL: Explanation for the separate profit in Quarter 4, 2014

Cuu Long Pharmaceutical Joint Stock Corporation explained the fluctuation in profit in the financial statements for Quarter 4/2014 compared to Quarter 4/2013 as follows:

-          Profit after tax in Quarter 4/2014: VND5,736,588,231

-          Profit after tax in Quarter 4/2013: VND4,085,518,598

Compared to the same period of last year, the profit after tax in the financial statements for Quarter 4/2014 increased VND 1,651,069,633 (more than 10%) because:

-          Financial expense decreased by 43% because the company strove to decrease in the borrowing balance of bank, which led to decrease in the borrowing expense. So after tax profit increased compared to the same period of last year.

HOSE

>   HSG: Information on business license of branch in Tho Xuan – Thanh Hoa (25/02/2015)

>   CMX: Explanation for business results in Quarter 4.2014 (25/02/2015)

>   DCL: Explanation for the consolidated profit in Quarter 4, 2014 (25/02/2015)

>   VSI: Explanation for parent company and consolidated business result in Q4, 2014 (25/02/2015)

>   HU3: Explanation for business result in Q4.2014 (25/02/2015)

>   STB: Explanation for separate business result in Quarter 4, 2014 (25/02/2015)

>   STB: Explanation for consolidated business result in Quarter 4, 2014 (25/02/2015)

>   FCM: Explanation for business result in Quarter 4, 2014 (25/02/2015)

>   APC: Explanation for business result in Q4.2014 (Single-entity FS) (25/02/2015)

>   APC: Explanation for business result in Q4.2014 (Consolidated FS) (25/02/2015)